| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.079 | 0.1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |